Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey. Show more

100 CAMPUS DRIVE, FLORHAM PARK, NJ, UNITED STATES, 07932, Florham Park, NJ, 07932, USA

https://www.cellectar.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

13.95M

52 Wk Range

$2.45 - $20.59

Previous Close

$3.29

Open

$3.34

Volume

27,705

Day Range

$3.11 - $3.40

Enterprise Value

2.348M

Cash

12.55M

Avg Qtr Burn

-4.275M

Insider Ownership

3.91%

Institutional Own.

8.12%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Iopofosine (CLR 131) Details Waldenstrom macroglobulinemia	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Iopofosine (CLR 131) Details Multiple myeloma, Cancer, High Refractory Multiple Myeloma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CLR 125 Details Triple-negative breast cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CLR 121125 Details Triple-negative breast cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Iopofosine (CLR 131) Details Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Iopofosine (CLR 131) + EBRT Details Head and neck cancer, Head and neck squamous cell carcinoma	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.